145 related articles for article (PubMed ID: 28087617)
1. In vitro activity of the antiasthmatic drug zafirlukast against the oral pathogens Porphyromonas gingivalis and Streptococcus mutans.
Gerits E; Van der Massen I; Vandamme K; De Cremer K; De Brucker K; Thevissen K; Cammue BPA; Beullens S; Fauvart M; Verstraeten N; Michiels J
FEMS Microbiol Lett; 2017 Jan; 364(2):. PubMed ID: 28087617
[TBL] [Abstract][Full Text] [Related]
2. Repurposing Toremifene for Treatment of Oral Bacterial Infections.
Gerits E; Defraine V; Vandamme K; De Cremer K; De Brucker K; Thevissen K; Cammue BP; Beullens S; Fauvart M; Verstraeten N; Michiels J
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993858
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria.
Yang KM; Kim JS; Kim HS; Kim YY; Oh JK; Jung HW; Park DS; Bae KH
Sci Rep; 2021 Jan; 11(1):1631. PubMed ID: 33452304
[TBL] [Abstract][Full Text] [Related]
4. An in vitro study of alginate oligomer therapies on oral biofilms.
Roberts JL; Khan S; Emanuel C; Powell LC; Pritchard MF; Onsøyen E; Myrvold R; Thomas DW; Hill KE
J Dent; 2013 Oct; 41(10):892-9. PubMed ID: 23907083
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal effect of extracts and metabolites of Robinia pseudoacacia L. on Streptococcus mutans and Porphyromonas gingivalis causing dental plaque and periodontal inflammatory diseases.
Patra JK; Kim ES; Oh K; Kim HJ; Dhakal R; Kim Y; Baek KH
Molecules; 2015 Apr; 20(4):6128-39. PubMed ID: 25856062
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of taurine haloamines and chlorhexidine against selected oral microbiome species].
Pasich E; Bialecka A; Marcinkiewicz J
Med Dosw Mikrobiol; 2013; 65(3):187-96. PubMed ID: 24432558
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial effect of copper-bearing titanium alloy (Ti-Cu) against Streptococcus mutans and Porphyromonas gingivalis.
Liu R; Memarzadeh K; Chang B; Zhang Y; Ma Z; Allaker RP; Ren L; Yang K
Sci Rep; 2016 Jul; 6():29985. PubMed ID: 27457788
[TBL] [Abstract][Full Text] [Related]
8. Effects of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives on biofilm formation by two oral pathogens, Porphyromonas gingivalis and Streptococcus mutans.
Bodet C; Epifano F; Genovese S; Curini M; Grenier D
Eur J Med Chem; 2008 Aug; 43(8):1612-20. PubMed ID: 18093697
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of hinokitiol against both antibiotic-resistant and -susceptible pathogenic bacteria that predominate in the oral cavity and upper airways.
Domon H; Hiyoshi T; Maekawa T; Yonezawa D; Tamura H; Kawabata S; Yanagihara K; Kimura O; Kunitomo E; Terao Y
Microbiol Immunol; 2019 Jun; 63(6):213-222. PubMed ID: 31106894
[TBL] [Abstract][Full Text] [Related]
10. Copaifera reticulata oleoresin: Chemical characterization and antibacterial properties against oral pathogens.
Bardají DK; da Silva JJ; Bianchi TC; de Souza Eugênio D; de Oliveira PF; Leandro LF; Rogez HL; Venezianni RC; Ambrosio SR; Tavares DC; Bastos JK; Martins CH
Anaerobe; 2016 Aug; 40():18-27. PubMed ID: 27118478
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-encapsulated chlorhexidine against oral bacterial biofilms.
Seneviratne CJ; Leung KC; Wong CH; Lee SF; Li X; Leung PC; Lau CB; Wat E; Jin L
PLoS One; 2014; 9(8):e103234. PubMed ID: 25170958
[TBL] [Abstract][Full Text] [Related]
12. In vitro assessment of stainless steel orthodontic brackets coated with titanium oxide mixed Ag for anti-adherent and antibacterial properties against Streptococcus mutans and Porphyromonas gingivalis.
Fatani EJ; Almutairi HH; Alharbi AO; Alnakhli YO; Divakar DD; Muzaheed ; Alkheraif AA; Khan AA
Microb Pathog; 2017 Nov; 112():190-194. PubMed ID: 28966064
[TBL] [Abstract][Full Text] [Related]
13. Evaluating biofilm growth of two oral pathogens.
Roberts SK; Wei GX; Wu CD
Lett Appl Microbiol; 2002; 35(6):552-6. PubMed ID: 12460443
[TBL] [Abstract][Full Text] [Related]
14. Development of resistance of mutans streptococci and Porphyromonas gingivalis to chlorhexidine digluconate and amine fluoride/stannous fluoride-containing mouthrinses, in vitro.
Kulik EM; Waltimo T; Weiger R; Schweizer I; Lenkeit K; Filipuzzi-Jenny E; Walter C
Clin Oral Investig; 2015 Jul; 19(6):1547-53. PubMed ID: 25483124
[TBL] [Abstract][Full Text] [Related]
15. Oral spray containing plant-derived compounds is effective against common oral pathogens.
Nittayananta W; Limsuwan S; Srichana T; Sae-Wong C; Amnuaikit T
Arch Oral Biol; 2018 Jun; 90():80-85. PubMed ID: 29573647
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of nanosilver-doped titanium implants for oral and maxillofacial surgery.
Pokrowiecki R; Zaręba T; Szaraniec B; Pałka K; Mielczarek A; Menaszek E; Tyski S
Int J Nanomedicine; 2017; 12():4285-4297. PubMed ID: 28652733
[TBL] [Abstract][Full Text] [Related]
17. High in vitro antibacterial activity of Pac-525 against Porphyromonas gingivalis biofilms cultured on titanium.
Li JY; Wang XJ; Wang LN; Ying XX; Ren X; Liu HY; Xu L; Ma GW
Biomed Res Int; 2015; 2015():909870. PubMed ID: 25710035
[TBL] [Abstract][Full Text] [Related]
18. Effect of a novel antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans biofilms.
Wang W; Tao R; Tong Z; Ding Y; Kuang R; Zhai S; Liu J; Ni L
Peptides; 2012 Feb; 33(2):212-9. PubMed ID: 22281025
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria.
Sun M; Zhou Z; Dong J; Zhang J; Xia Y; Shu R
Microb Pathog; 2016 Oct; 99():196-203. PubMed ID: 27565090
[TBL] [Abstract][Full Text] [Related]
20. Agglutination of Streptococcus mutans serotype C cells but inhibition of Porphyromonas gingivalis autoaggregation by human lactoferrin.
Soukka T; Tenovuo J; Rundegren J
Arch Oral Biol; 1993 Mar; 38(3):227-32. PubMed ID: 8387771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
